Bruker and the University of Victoria-Genome British Columbia Proteomics Centre have announced a collaborative effort for the development and validation of high-throughput assays for determining hemoglobin variants and diabetes risk, using Bruker´s MALDI Biotyper platform for clinical mass spectrometry, and based on intellectual property developed at the UVic GBC Proteomics Centre.
The journal Biochemistry has recognized the publication titled "Structure and Dynamics of Small Soluble Aβ(1–40) Oligomers Studied by Top-Down Hydrogen Exchange Mass Spectrometry," a collaboration between the Proteomics Centre and the Konermann group at The University of Western Ontario. Congratulations to the authors involved.
The journal Science Translational Medicine has chosen a paper published in collaboration with Dr. Antunes of the University of British Columbia as an "Editors Choice" for Vol. 4, Issue 126. The article discusses the paper, and can be viewed online here. (Free site registration required).